Palstatin

Details

Top
Internal ID c7a5de0b-2be6-4223-8d8b-343e55464768
Taxonomy Lignans, neolignans and related compounds > Flavonolignans
IUPAC Name 5,7-dihydroxy-2-[(2R,3R)-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl]chromen-4-one
SMILES (Canonical) COC1=CC(=CC(=C1O)OC)C2C(OC3=C(O2)C=C(C=C3OC)C4=CC(=O)C5=C(C=C(C=C5O4)O)O)CO
SMILES (Isomeric) COC1=CC(=CC(=C1O)OC)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3OC)C4=CC(=O)C5=C(C=C(C=C5O4)O)O)CO
InChI InChI=1S/C27H24O11/c1-33-19-6-13(7-20(34-2)25(19)32)26-23(11-28)38-27-21(35-3)4-12(5-22(27)37-26)17-10-16(31)24-15(30)8-14(29)9-18(24)36-17/h4-10,23,26,28-30,32H,11H2,1-3H3/t23-,26-/m1/s1
InChI Key KIEFQALNZCXSHH-ZEQKJWHPSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C27H24O11
Molecular Weight 524.50 g/mol
Exact Mass 524.13186158 g/mol
Topological Polar Surface Area (TPSA) 153.00 Ų
XlogP 3.20
Atomic LogP (AlogP) 3.48
H-Bond Acceptor 11
H-Bond Donor 4
Rotatable Bonds 6

Synonyms

Top
CHEMBL523569
SCHEMBL14829819
5,7-dihydroxy-2-[(2R,3R)-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-5-methoxy-2,3-dihydro-1,4-benzodioxin-7-yl]chromen-4-one
4H-1-benzopyran-4-one, 2-[(2R,3R)-2,3-dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-8-methoxy-1,4-benzodioxin-6-yl]-5,7-dihydroxy-
5,7-Dihydroxy-2-[3-(4-hydroxy-3,5-dimethoxy-phenyl)-2-hydroxymethyl-8-methoxy-2,3-dihydro-benzo[1,4]dioxin-6-yl]-chromen-4-one
InChI=1/C27H24O11/c1-33-19-6-13(7-20(34-2)25(19)32)26-23(11-28)38-27-21(35-3)4-12(5-22(27)37-26)17-10-16(31)24-15(30)8-14(29)9-18(24)36-17/h4-10,23,26,28-30,32H,11H2,1-3H3/t23-,26-/m1/s
rel-5,7-dihydroxy-2-[(2R,3R)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl]-4H-chromen-4-one

2D Structure

Top
2D Structure of Palstatin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8893 88.93%
Caco-2 - 0.7648 76.48%
Blood Brain Barrier - 0.7750 77.50%
Human oral bioavailability - 0.6857 68.57%
Subcellular localzation Mitochondria 0.6699 66.99%
OATP2B1 inhibitior - 0.7097 70.97%
OATP1B1 inhibitior + 0.8567 85.67%
OATP1B3 inhibitior - 0.3164 31.64%
MATE1 inhibitior - 0.6200 62.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior + 0.9341 93.41%
P-glycoprotein inhibitior + 0.9331 93.31%
P-glycoprotein substrate - 0.5545 55.45%
CYP3A4 substrate + 0.6306 63.06%
CYP2C9 substrate - 0.6235 62.35%
CYP2D6 substrate - 0.8293 82.93%
CYP3A4 inhibition - 0.5928 59.28%
CYP2C9 inhibition - 0.6736 67.36%
CYP2C19 inhibition - 0.7375 73.75%
CYP2D6 inhibition - 0.9170 91.70%
CYP1A2 inhibition - 0.8181 81.81%
CYP2C8 inhibition + 0.7305 73.05%
CYP inhibitory promiscuity + 0.6513 65.13%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.7217 72.17%
Eye corrosion - 0.9863 98.63%
Eye irritation - 0.8525 85.25%
Skin irritation - 0.8350 83.50%
Skin corrosion - 0.9670 96.70%
Ames mutagenesis - 0.5928 59.28%
Human Ether-a-go-go-Related Gene inhibition + 0.6986 69.86%
Micronuclear + 0.6559 65.59%
Hepatotoxicity - 0.6375 63.75%
skin sensitisation - 0.8982 89.82%
Respiratory toxicity + 0.7000 70.00%
Reproductive toxicity + 0.7444 74.44%
Mitochondrial toxicity - 0.5250 52.50%
Nephrotoxicity - 0.6774 67.74%
Acute Oral Toxicity (c) III 0.6807 68.07%
Estrogen receptor binding + 0.8922 89.22%
Androgen receptor binding + 0.7585 75.85%
Thyroid receptor binding + 0.6592 65.92%
Glucocorticoid receptor binding + 0.8663 86.63%
Aromatase binding + 0.5898 58.98%
PPAR gamma + 0.7465 74.65%
Honey bee toxicity - 0.6908 69.08%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity - 0.6600 66.00%
Fish aquatic toxicity - 0.4517 45.17%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.37% 91.11%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 97.76% 85.14%
CHEMBL1806 P11388 DNA topoisomerase II alpha 94.96% 89.00%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 94.28% 94.00%
CHEMBL2581 P07339 Cathepsin D 94.10% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.70% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.53% 96.09%
CHEMBL3194 P02766 Transthyretin 89.72% 90.71%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 89.18% 86.92%
CHEMBL1293249 Q13887 Kruppel-like factor 5 88.71% 86.33%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.28% 97.09%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 86.11% 99.23%
CHEMBL3231 Q13464 Rho-associated protein kinase 1 83.58% 95.55%
CHEMBL3060 Q9Y345 Glycine transporter 2 83.44% 99.17%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 83.36% 92.62%
CHEMBL3401 O75469 Pregnane X receptor 83.19% 94.73%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 82.64% 95.50%

Cross-Links

Top
PubChem 5323578
NPASS NPC101731
LOTUS LTS0105069
wikiData Q105141468